NCT00171015View on ClinicalTrials.gov

VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan Medoxomil

PHASE3CompletedINTERVENTIONAL
Enrollment

212

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

April 30, 2005

Study Completion Date

April 30, 2005

Conditions
Hypertension
Interventions
DRUG

valsartan plus hydrochlorothiazide

Trial Locations (2)

Unknown

Multiple Locations

Novartis Pharmaceuticals, Basel

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY